Propiverine
Top View
- Drug Delivery Approaches for Managing Overactive Bladder (OAB): a Systematic Review
- Efficacy, Tolerability and Safety of Propiverine Hydrochloride In
- Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
- Results: 5 Anticholinergic Medication Use for Female Overactive Bladder In
- The Pharmacology of Svt-40776, a New Muscarinic Antagonist for the Treatment of Urinary Incontinence
- Centre for Reviews and Dissemination
- Recommendation from the New Drugs Committee
- The Role of Muscarinic Receptor Subtypes on Carbachol-Induced Contraction of Normal Human Detrusor and Overactive Detrusor Assoc
- NVA237 / Glycopyrronium Bromide Multinational, Multi-Database Cohort
- Analysis of Pharmacological Effects of Drugs Used for Treatment of Urinary Disturbance Based on Anticholinergic and Smooth Muscle- Relaxing Effects
- 334 Adverse Events of Anticholinergic Drugs For
- DIAGNOSIS and TREATMENT of OVERACTIVE BLADDER (Non-Neurogenic) in ADULTS: AUA/SUFU GUIDELINE
- Flavoxate: Present and Future
- Report and Evidence Tables
- The Anticholinergic Drug Propiverine Inhibits the Protein Kinase C Activity in the Rat Urinary Bladder
- Supplemental Table 2. Summary of Adherence and Persistence Rates and Determinants
- The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Poorly Responded to Previous Anticholinergic Agents
- (12) Patent Application Publication (10) Pub. No.: US 2017/0056347 A1 Glick Et Al